We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

17 hedge funds and large institutions have $24.8M invested in Albireo Pharma Inc in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

43% more capital invested

Capital invested by funds: $17.3M → $24.8M (+$7.47M)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

11% less funds holding

Funds holding: 19 → 17 (-2)

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
4
Calls
$60K
Puts
–
Net Calls
+$60K
Net Calls Change
-$557K

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$794K
2
SAM
Sectoral Asset Management
Quebec, Canada
+$440K
3
SCM
Segantii Capital Management
Hong Kong
+$46.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$30.5K
5
BlackRock
BlackRock
New York
+$19.1K

Top Sellers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
-$64K
2
Deutsche Bank
Deutsche Bank
Germany
-$21K
3
Group One Trading
Group One Trading
Illinois
-$14.3K
4
Morgan Stanley
Morgan Stanley
New York
-$8K
5
Bank of America
Bank of America
North Carolina
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TGHSA
1
TPG Group Holdings (SBS) Advisors
Texas
$18.6M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$3.59M +$17.3K +794 +0.5%
OM
3
Opaleye Management
Massachusetts
$876K +$794K +36,500 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$717K +$30.5K +1,404 +5%
SAM
5
Sectoral Asset Management
Quebec, Canada
$485K +$440K +20,224 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$329K +$12.8K +588 +4%
PVH
7
Psagot Value Holdings
Israel
$57K – – –
SCM
8
Segantii Capital Management
Hong Kong
$51K +$46.1K +2,120 New
BlackRock
9
BlackRock
New York
$21K +$19.1K +880 New
Group One Trading
10
Group One Trading
Illinois
$14K -$14.3K -655 -52%
CG
11
Cutler Group
California
$14K – – –
UBS Group
12
UBS Group
Switzerland
$6K +$5.31K +244 +24,400%
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$1K – – –
NSIM
14
North Star Investment Management
Illinois
$1K – – –
PMFA
15
Plante Moran Financial Advisors
Michigan
$1K – – –
PAM
16
Panagora Asset Management
Massachusetts
– -$64K -3,620 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$21K -1,246 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$8K -451 Closed
Bank of America
19
Bank of America
North Carolina
– -$3K -200 Closed

ALBO Hedge Fund Activity: Q1 2017 in Review

17 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2017, worth a combined $24.8M — up 43% from $17.3M a quarter earlier.

Fund positioning in ALBO was balanced in Q1 2017: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $794K. The largest seller was Panagora Asset Management, exiting entirely with an estimated $64K sold.

  • 17 institutional investors held Albireo Pharma Inc (ALBO) as of Q1 2017, down from 19 in Q4 2016.
  • Funds reported $24.8M of Albireo Pharma Inc stock for Q1 2017, up 43% quarter-over-quarter.
  • 4 funds opened new Albireo Pharma Inc positions in Q1 2017 and 4 closed out, a net change of 0 holders.
  • The largest Albireo Pharma Inc buyer in Q1 2017 was Opaleye Management, an estimated $794K added.
  • The largest Albireo Pharma Inc seller in Q1 2017 was Panagora Asset Management, an estimated $64K sold.

Based on aggregated 13F filings for Q1 2017.